Soleno Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	133.03	70.11	87.93	169.68	14.6	21.3
Short-Term Investments	122.57	235.37	203.51	-	-	-
Cash & Short-Term Investments	255.6	305.47	291.44	169.68	14.6	21.3
Cash Growth	-11.85%	4.82%	71.76%	1062.04%	-31.46%	-56.72%
Accounts Receivable	47.14	28.21	-	-	-	-
Inventory	17.31	15.02	-	-	-	-
Other Current Assets	6.33	7.11	2.45	1.68	1.05	1.12
Total Current Assets	326.38	355.81	293.89	171.36	15.65	22.42
Net Property, Plant & Equipment	4.09	2.38	2.98	0.42	0.16	0.45
Other Intangible Assets	4.37	4.86	6.81	8.75	10.69	12.64
Long-Term Investments	273.38	200.62	27.21	-	-	-
Other Long-Term Assets	0.16	0.16	0.08	0.17	-	0.04
Total Assets	608.39	563.83	330.97	180.69	26.5	35.55
Accounts Payable	12.39	12.44	8.88	3.15	1.78	3.25
Accrued Expenses	5.72	9.68	4.78	6.53	4.9	4.15
Current Portion of Leases	1.16	0.73	0.53	0.27	0.16	0.28
Other Current Liabilities	38.78	38.53	4.56	1.56	0.48	0.32
Total Current Liabilities	58.05	61.36	18.75	11.51	7.31	8.01
Long-Term Debt	49.87	49.86	49.83	-	-	-
Long-Term Leases	3.24	1.96	2.47	0.13	-	0.18
Other Long-Term Liabilities	1.43	0.53	14.81	11.55	8.84	9.58
Total Long-Term Liabilities	54.54	52.35	67.11	11.68	8.84	9.75
Total Liabilities	112.59	113.72	85.86	23.18	16.15	17.76
Common Stock	0.05	0.05	0.05	0.03	0.01	0.08
Additional Paid-in Capital	897.58	881.02	696.97	433.89	247.76	231.07
Accumulated Other Comprehensive Income	-1.84	0.42	0.36	-	-	-
Retained Earnings	-399.99	-431.37	-452.26	-276.41	-237.42	-213.36
Shareholders' Equity	495.8	450.12	245.11	157.51	10.35	17.79
Total Liabilities & Equity	608.39	563.83	330.97	180.69	26.5	35.55
Total Debt	54.28	52.55	52.83	0.4	0.16	0.46
Net Cash (Debt)	201.32	252.92	238.61	169.28	14.45	20.85
Net Cash Growth	-20.40%	6.00%	40.96%	1071.72%	-30.70%	-57.53%
Net Cash Per Share	3.78	4.83	5.94	10.26	1.72	3.92
Book Value	495.8	450.12	245.11	157.51	10.35	17.79
Book Value Per Share	9.32	8.59	6.10	9.55	1.23	3.35
Tangible Book Value	491.43	445.25	238.31	148.76	-0.35	5.16
Tangible Book Value Per Share	9.24	8.50	5.93	9.02	-0.04	0.97

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q